SCOR Global Life, a subsidiary of France-based reinsurance firm SCOR, has teamed up with wearable technology company Garmin Health to improve its underwriting in Asia Pacific region. Under the terms of the agreement, Garmin Health will support SCOR Global Life’s Biological Age Model (BAM) to integrate more biometric data into its algorithm and offer underwriting insights. Leveraging the collaboration, SCOR will allow insurers to get more accurate assessment of an individual’s biological age and reduce risk and purchase cycles and offer competitive pricing. Additionally, it will strengthen BAM’s adaptability for various markets. Through BAM, policyholders whose biological age is lower than their chronological age, can receive incentives including premium discounts, health and wellness coaching, and rewards, among others SCOR Global Life Asia-Pacific deputy CEO Vincent Lepez said: “We are excited about the Garmin collaboration as it underscores the real value of BAM by a leader in the wearables industry. Loading ... “We are starting the year strong with two project launches, one in China (JD China) and one in Malaysia (Hong Leong Assurance), and we will be continuing this momentum in the coming months by bringing more BAM and Garmin products into several markets across the region. “Our unwavering commitment to enhancing BAM mirrors our passion to help people lead healthier lives.” Garmin Health director of global business development Joern Watzke said: “Combining the health data from Garmin wearables with the analytical capabilities of BAM creates a powerful solution for both insurance companies and their customers.”
SCOR Global Life and Garmin Health have joined forces to improve SCOR’s Asia Pacific (APAC) underwriting operation. The wearable technology company will back the insurance firm’s Global Life Asia-Pacific (BAM) to increase the biometric data in its algorithm and improve underwriting insights. The partnership will allow SCOR to improve its assessment of an individual’s biological age to reduce risks and costs. Clients whose biological age is lower than their chronological age will be offered rewards and incentives. The deal is expected to make BAM more adaptable to various markets in the APAC region.